In collaboration with Scientists and Clinicians at TRIUMF and the BCC, we initiated the first 18F-EF5 PET clinical studies in Canada for lung cancer and prostate cancer. Further studies to examine hypoxia in ovarian, and head and neck cancers have also been carried out. Pre-clinical studies carried out by my group formed the impetus for the clinical studies. Our group also supported the production 18F-EFT for clinical use.
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.